# Jeil Pharmaceutical Co., Ltd.

Organization · id `cardio:org-jeil-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Jeil+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Jeil Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia (`cardio:ct-nct02827903`)
- Sponsors: Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke (`cardio:ct-nct03062397`)
- Sponsors: To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin (`cardio:ct-nct05101135`)
- Sponsors: To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin (`cardio:ct-nct05296044`)
- Sponsors: The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) (`cardio:ct-nct05820048`)
- Sponsors: Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients (`cardio:ct-nct06144788`)
- Sponsors: Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke (`cardio:ct-nct07730840`)

## Provenance

Content hash: e18069f1a174379762ae67bd1abd74584031899695c767c390fabc586b60d1db
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
